AtriCure Inc (ATRC) - Total Assets
Based on the latest financial reports, AtriCure Inc (ATRC) holds total assets worth $676.64 Million USD as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
AtriCure Inc - Total Assets Trend (2001–2025)
This chart illustrates how AtriCure Inc's total assets have evolved over time, based on quarterly financial data. Also see AtriCure Inc market capitalisation for the company's overall valuation and market capitalisation.
AtriCure Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
AtriCure Inc's total assets of $676.64 Million consist of 49.3% current assets and 50.7% non-current assets. Review total liabilities of AtriCure Inc to assess the company's total debt and financial obligations.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 25.6% |
| Accounts Receivable | $66.65 Million | 10.2% |
| Inventory | $78.49 Million | 12.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $48.03 Million | 7.3% |
| Goodwill | $234.78 Million | 35.9% |
Asset Composition Trend (2001–2025)
This chart illustrates how AtriCure Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See AtriCure Inc stock quote for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: AtriCure Inc's current assets represent 49.3% of total assets in 2025, an increase from 0.0% in 2001.
- Cash Position: Cash and equivalents constituted 25.6% of total assets in 2025, up from 0.0% in 2001.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 42.0% of total assets, an increase from 0.0% in 2001.
- Asset Diversification: The largest asset category is goodwill at 35.9% of total assets.
AtriCure Inc Competitors by Total Assets
Key competitors of AtriCure Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Andon Health Co Ltd
SHE:002432
|
China | CN¥29.91 Billion |
|
Tinavi Medical Technologies Co Ltd
SHG:688277
|
China | CN¥1.64 Billion |
|
Mark Dynamics Indonesia Tbk PT
JK:MARK
|
Indonesia | Rp980.33 Billion |
|
Interojo Inc
KQ:119610
|
Korea | ₩252.22 Billion |
|
Daxor Corporation
NASDAQ:DXR
|
USA | $35.90 Million |
|
Ansell Ltd
AU:ANN
|
Australia | AU$3.33 Billion |
|
Nanosonics Ltd
AU:NAN
|
Australia | AU$279.25 Million |
|
SDI Ltd
AU:SDI
|
Australia | AU$135.84 Million |
AtriCure Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.22 | 3.94 | 3.63 |
| Quick Ratio | 3.19 | 2.83 | 2.91 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $263.62 Million | $202.41 Million | $141.75 Million |
AtriCure Inc - Advanced Valuation Insights
This section examines the relationship between AtriCure Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 4.10 |
| Latest Market Cap to Assets Ratio | 3.38 |
| Asset Growth Rate (YoY) | 7.4% |
| Total Assets | $654.18 Million |
| Market Capitalization | $2.21 Billion USD |
Valuation Analysis
Premium Asset Valuation: The market values AtriCure Inc's assets at a significant premium (3.38x), suggesting investors see substantial growth potential or unique competitive advantages.
Positive Asset Growth: AtriCure Inc's assets grew by 7.4% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for AtriCure Inc (2001–2025)
The table below shows the annual total assets of AtriCure Inc from 2001 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $654.18 Million | +7.36% |
| 2024-12-31 | $609.33 Million | -0.75% |
| 2023-12-31 | $613.93 Million | +4.87% |
| 2022-12-31 | $585.45 Million | -4.85% |
| 2021-12-31 | $615.31 Million | -13.89% |
| 2020-12-31 | $714.54 Million | +28.08% |
| 2019-12-31 | $557.88 Million | +56.37% |
| 2018-12-31 | $356.76 Million | +33.27% |
| 2017-12-31 | $267.70 Million | -3.15% |
| 2016-12-31 | $276.42 Million | +1.22% |
| 2015-12-31 | $273.09 Million | +72.40% |
| 2014-12-31 | $158.40 Million | +41.50% |
| 2013-12-31 | $111.95 Million | +245.19% |
| 2012-12-31 | $32.43 Million | -4.22% |
| 2011-12-31 | $33.86 Million | +0.42% |
| 2010-12-31 | $33.72 Million | -3.62% |
| 2009-12-31 | $34.98 Million | -19.34% |
| 2008-12-31 | $43.37 Million | -5.87% |
| 2007-12-31 | $46.07 Million | +17.75% |
| 2006-12-31 | $39.13 Million | -21.81% |
| 2005-12-31 | $50.04 Million | +293.07% |
| 2004-12-31 | $12.73 Million | -13.74% |
| 2003-12-31 | $14.76 Million | -16.08% |
| 2002-12-31 | $17.59 Million | +757.44% |
| 2001-12-31 | $2.05 Million | -- |
About AtriCure Inc
AtriCure, Inc. engages in the development, manufacture, and sale of devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, the Asia-Pacific, and internationally. It offers Isolator Synergy Ablation System clamps, a single-use disposable radio frequency products; m… Read more